TY - JOUR
T1 - Degradation of amyloid A and serum amyloid A by red blood cell haemolysate in patients with familial mediterranean fever
AU - SHAINKIN‐KESTENBAUM, RUTH
AU - WINIKOFF, YEHUDIT
AU - ZIMLICHMAN, SHULAMIT
AU - GORODISCHER, RAFAEL
AU - PRAS, MORDECHAI
PY - 1984/1/1
Y1 - 1984/1/1
N2 - Abstract. Enzymatic activity for the degradation of serum amyloid A (SAA) and amyloid A (AA) was detected in erythrolysates of normal subjects and patients with familial mediterranean fever. A significant difference between the activity of normal subjects and patients was not found. Serum inhibited the SAA (but not the AA) haemolysate proteolytic activity. Interindividual variation in the susceptibility of SAA to degradation by RBC haemolysates was shown. The original digestible fraction of SAA became gradually resistant to proteolytic cleavage over a 9 month period while the susceptibility of AA to degradation remained unchanged in this time period. These findings suggest that enzymatic degradation of SAA depends on the source of SAA, as well as inhibitory activity in serum.
AB - Abstract. Enzymatic activity for the degradation of serum amyloid A (SAA) and amyloid A (AA) was detected in erythrolysates of normal subjects and patients with familial mediterranean fever. A significant difference between the activity of normal subjects and patients was not found. Serum inhibited the SAA (but not the AA) haemolysate proteolytic activity. Interindividual variation in the susceptibility of SAA to degradation by RBC haemolysates was shown. The original digestible fraction of SAA became gradually resistant to proteolytic cleavage over a 9 month period while the susceptibility of AA to degradation remained unchanged in this time period. These findings suggest that enzymatic degradation of SAA depends on the source of SAA, as well as inhibitory activity in serum.
KW - Amyloid A
KW - familial mediterranean fever
KW - red blood cell haemolysate
KW - serum amyloid A
UR - http://www.scopus.com/inward/record.url?scp=0021184416&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2362.1984.tb01201.x
DO - 10.1111/j.1365-2362.1984.tb01201.x
M3 - Article
C2 - 6437839
AN - SCOPUS:0021184416
SN - 0014-2972
VL - 14
SP - 398
EP - 401
JO - European Journal of Clinical Investigation
JF - European Journal of Clinical Investigation
IS - 5
ER -